Showing 1981-1990 of 2530 results for "".
- Alastin Launches Sensitive Skincare Collectionhttps://modernaesthetics.com/news/alastin-launches-sensitive-skincare-collection/2473154/Alastin’s new sensitive skin collection has launched with three sensitive skincare products: Ultra Calm Cleansing Cream, Ultra Light Moisturizer with TriHex Technology® and SilkSHIELD All-Mineral Sunscreen SPF 30 with TriHex Technology®. The collection includes ultra-calming, restor
- Galderma's Restylane Turns 25!https://modernaesthetics.com/news/galdermas-restylane-turns-25/2473147/Galderma’s Restylane is celebrating 25 years on the market. Since launching in Europe in 1996, Restylane has celebrated many milestones across the globe. This includes the first approval for use by the U.S. Food and Drug Administration (FDA) in 2003 and in China by the Nation
- ellacor Maker Cytrellis Closes Funding Roundhttps://modernaesthetics.com/news/ellacor-maker-cytrellis-closes-funding-round/2473145/Cytrellis has closed a $50 million Series C funding round. The financing was led by D1 Capital Partners and included participation from an additional new investor, Sands Capital, as well as existing institutional investors, ARCH Venture Partners and PFM Health Sciences. Proceeds will be
- It’s Over: AbbVie, BTL Settle Muscle Stimulation Patent Disputehttps://modernaesthetics.com/news/its-over-abbvie-btl-settle-patent-dispute/2473143/BTL Industries has resolved its patent infringement claims against AbbVie related to BTL's muscle stimulation technology. Under the terms of the settlement agreement, AbbVie will pay BTL an undisclosed payment. The details of the agreement are confidential and will not be disc
- Sientra’s Allox2 Helps Manage Seroma and Infection in Prepectoral Breast Reconstructionhttps://modernaesthetics.com/news/sientras-allox2s-helps-manage-seroma-and-infection-in-prepectoral-breast-reconstruction/2473138/The Sientra Allox2 dual port tissue expander enables efficient management of seroma and early targeted intervention in prepectoral breast reconstruction, according to a new study on PRS Global Open. Seroma are among the most common complications after staged prepectoral implant
- Alisa Lask Joins CollPlant’s Board of Directorshttps://modernaesthetics.com/news/alisa-lask-joins-collplants-board-of-directors/2473137/Industry vet Alisa Lask is now a member of CollPlant’s Board of Directors. Ms. Lask is based in the United States and has held leadership roles in medical aesthetics at both Galderma and Allergan. She will be the seventh independent member of the CollPlan
- Sciton Launches mJOULE in Canadahttps://modernaesthetics.com/news/sciton-launches-mjoule-in-canada/2473136/Sciton Inc. is launching the new mJOULE platform in Canada. This system features the company's newest fractional treatment MOXI and BBL HERO treatment. "Part of Sciton's global growth strategy is to ensure our partners and their
- As Aging Population Increases, Medical Aesthetics Market is Predicted to Growhttps://modernaesthetics.com/news/as-aging-population-increases-medical-aesthetics-market-is-predicted-to-grow/2473135/The global Medical Aesthetics Market, valued at USD 10.1 billion in 2018, is expected to reach USD 20.4 billion in 2026, growing at a CAGR of 9.0% during the forecast period, according to the latest report from All
- Study Tracks Increased Sadness, Fear, Disgust Among Healthcare Workers Linked to COVID-19https://modernaesthetics.com/news/study-tracks-increased-sadness-fear-disgust-among-healthcare-workers-linked-to-covid-19/2473134/Researchers discovered patterns of significantly decreased joy, increased sadness, fear and disgust among health care professionals (HCP) during the COVID-19 pandemic. The study, led by researchers at Ben-Gurion University of the
- Elite World Group Taps Elysium Health to Develop Science-First Skincare Linehttps://modernaesthetics.com/news/elite-world-group-taps-leading-elysium-health-to-develop-science-first-skincare-line/2473133/Elysium Health, Inc. is joining forces with Elite World Group to develop a line of skincare products. Launching in spring 2022, the line is currently in development and will be sold under an independent trademark. Elite World Group's talent media network, paired wit